Sacubitril/Valsartan Ameliorates Crizotinib-Induced Cardiotoxicity in Mice

Background: Lung cancer is one of the major cause of death globally. Crizotinib is a first-line drug used in treating non-small-cell lung cancer (NSCLC). However, the pathophysiological mechanisms underlying its cardiotoxicity are unknown. This study investigated the mechanisms of crizotinib-induced...

Full description

Bibliographic Details

Published in:	Reviews in Cardiovascular Medicine
Main Authors:	Lijun Cheng, Junying Duan, Gary Tse, Tong Liu, Guangping Li
Format:	Article
Language:	English
Published:	IMR Press 2023-07-01
Subjects:	cardiotoxicity crizotinb sacubitril/valsartan myh7
Online Access:	https://www.imrpress.com/journal/RCM/24/7/10.31083/j.rcm2407192